VivoSeq
Other

Randomized

1

Pipeline Programs↗

46

Active Trials↗

65

Companies Involved↗

Randomized is an early-stage landscape with 1 program across 65 companies. The most active players are Changchun GeneScience Pharmaceutical Co., Ltd., Pfizer, Novartis.

Intelligence

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

41/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Changchun GeneScience Pharmaceutical Co., Ltd. logo

Changchun GeneScience Pharmaceutical Co., Ltd.

2 programs

Phase 1Pfizer logo

Pfizer

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Gensci142

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

390

clinical trials

Completed265 · 68%
Terminated30 · 8%
Unknown status30 · 8%
Recruiting23 · 6%
Withdrawn18 · 5%
Not yet recruiting11 · 3%
Other13 · 3%

Clinical Trials

Trial Activity

390 trials

tTF-NGR Randomized Study - STS
Recruiting·UUniversität Münster·Phase 3·NCT05597917·126 enrolled
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial
Recruiting·FFondation Ophtalmologique Adolphe de Rothschild·Phase 3·NCT05999604·244 enrolled
Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.
Recruiting·IInstitut Curie·Phase 3·NCT05439005·158 enrolled
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment
Recruiting·FFondazione IRCCS Istituto Nazionale dei Tumori, Milano·N/A·NCT05649943·566 enrolled
The Basel BOMP-AID Randomized Trial
Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 4·NCT03438526·190 enrolled
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Recruiting·NNorth American Science Associates Ltd.·N/A·NCT06872567·126 enrolled
Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial
Recruiting·UUniversity of Utah·Phase 2·NCT04944836·58 enrolled
Chitosan Irrigation in Premolar Root Canal Therapy (Randomized Trial)
Recruiting·EESRA DAĞCI·N/A·NCT07048028·90 enrolled
Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus
Recruiting·CChromaDex, Inc.·Phase 1·NCT07251608·40 enrolled
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Recruiting·VVA Office of Research and Development·Phase 2·NCT06084338·60 enrolled
Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial
Recruiting·FFoundation University Islamabad·Phase 1·NCT07479290·30 enrolled
Randomized Study Using SM-030 Gel for Adults With Melasma
Recruiting·DDermBiont, Inc.·Phase 2·NCT06454747·138 enrolled
Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial
Recruiting·—·Phase 2·NCT06700798·90 enrolled
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Recruiting·XXijing Hospital of Digestive Diseases·Phase 3·NCT07296458·132 enrolled
Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts
Recruiting·LLabo'Life·Phase 4·NCT03977753·162 enrolled
Page 1 of 26

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)